Drug Approval | December 28, 2022
Aurobindo's subsidiary Tergene Biotech receives SEC recommendation for pneumococcal 15 valent vaccine
The company continue to develop this program for the WHO markets, thereby providing coverage and protection for more infants globally in time to come
